These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 16515271)
21. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly. Stillman MJ; Stillman MT Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094 [TBL] [Abstract][Full Text] [Related]
22. The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults. Wilson SL; Poulter NR J Hypertens; 2006 Aug; 24(8):1457-69. PubMed ID: 16877945 [TBL] [Abstract][Full Text] [Related]
23. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591 [TBL] [Abstract][Full Text] [Related]
24. [Insight on the clinical pharmacology of non-steroidal anti-inflammatory drugs]. Maddison JE Tijdschr Diergeneeskd; 2010 Jan; 135(2):54-8. PubMed ID: 20344966 [No Abstract] [Full Text] [Related]
27. Etoricoxib: new drug. Avoid using cox-2 inhibitors for pain. Prescrire Int; 2007 Dec; 16(92):223-7. PubMed ID: 18084859 [TBL] [Abstract][Full Text] [Related]
28. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs]. Lange H; Eberhart L Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul; 42(7):514-7. PubMed ID: 17661262 [TBL] [Abstract][Full Text] [Related]
29. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336 [TBL] [Abstract][Full Text] [Related]
30. Back to the future: postoperative pain management beyond COX-2 inhibitors. Naesh O N Z Med J; 2006 Sep; 119(1242):U2170. PubMed ID: 16998571 [TBL] [Abstract][Full Text] [Related]
31. The COX-2 controversy continues ...but NSAIDs are still in the lead. New studies shed light on risks associated with popular arthritis painkillers. Health News; 2006 Aug; 12(8):3-4. PubMed ID: 16913025 [No Abstract] [Full Text] [Related]
32. [Study results of routine clinical practice. Do rheumatism patients get substandard care?]. MMW Fortschr Med; 2005 Nov; 147(47):63. PubMed ID: 16370199 [No Abstract] [Full Text] [Related]
33. [COX-2 inhibitors and other non-steroidal anti-inflammatory agents--what is their future?]. Gøtzsche PC Ugeskr Laeger; 2006 May; 168(20):1972-4. PubMed ID: 16768898 [TBL] [Abstract][Full Text] [Related]
35. Adverse cardiovascular effects of NSAIDs: driven by blood pressure, or edema? Aneja A; Farkouh ME Ther Adv Cardiovasc Dis; 2008 Feb; 2(1):53-66. PubMed ID: 19124408 [TBL] [Abstract][Full Text] [Related]
36. [Non-selective NSAIDs and coxibs: what are myths, what are facts?]. MMW Fortschr Med; 2013 Jun; 155(12):56-7. PubMed ID: 23923320 [No Abstract] [Full Text] [Related]
37. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers. Elnachef N; Scheiman JM; Fendrick AM; Howden CW; Chey WD Aliment Pharmacol Ther; 2008 Nov; 28(10):1249-58. PubMed ID: 18729848 [TBL] [Abstract][Full Text] [Related]
39. Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease. Whelton A Am J Cardiol; 2006 May; 97(9A):3-9. PubMed ID: 16675316 [TBL] [Abstract][Full Text] [Related]
40. Update on the role of nonsteroidal anti-inflammatory drugs and coxibs in the management of acute pain. Reuben SS Curr Opin Anaesthesiol; 2007 Oct; 20(5):440-50. PubMed ID: 17873597 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]